Indaptus Therapeutics Inc
General ticker "INDP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $9.4M
Indaptus Therapeutics Inc does not follow the US Stock Market performance with the rate: -21.4%.
Estimated limits based on current volatility of 4.1%: low 0.88$, high 0.96$
Factors to consider:
- Current price 38.7% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.45$, 3.67$]
- 2024-12-30 to 2025-12-30 estimated range: [1.47$, 3.63$]
Financial Metrics affecting the INDP estimates:
- Negative: Non-GAAP EPS, $ of -1.84 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -44.10 <= 2.35
- Positive: Interest expense per share, $ of 0 <= 0
Short-term INDP quotes
Long-term INDP plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $7.73MM | $14.91MM | $16.38MM |
| Operating Income | $-7.73MM | $-14.91MM | $-16.38MM |
| Non-Operating Income | $0.02MM | $0.59MM | $0.96MM |
| R&D Expense | $2.52MM | $6.32MM | $7.62MM |
| Income(Loss) | $-7.71MM | $-14.32MM | $-15.42MM |
| Profit(Loss) | $-7.71MM | $-14.32MM | $-15.42MM |
| Stockholders Equity | $35.90MM | $24.63MM | $12.08MM |
| Assets | $40.58MM | $28.06MM | $14.92MM |
| Operating Cash Flow | $-11.29MM | $-13.08MM | $-13.41MM |
| Capital expenditure | $0.00MM | $0.17MM | $0.00MM |
| Investing Cash Flow | $0.45MM | $-16.43MM | $17.14MM |
| Financing Cash Flow | $48.34MM | $0.00MM | $0.00MM |
| Earnings Per Share* | $-1.88 | $-1.66 | $-1.84 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.